Medical Innovation in Israel: Cancer Care Is Moving from One-Size-Fits-All to Precision Medicine

Genomic and molecular profiling can identify mutations and biomarkers that help specialists select more relevant treatment options. Targeted therapies act on specific cancer pathways, while immunotherapy can help the immune system recognize and attack cancer cells.

[1][2][3]

Theranostics takes personalization further: a molecular target can first be imaged to see whether it reaches the tumor. When appropriate, the same target can then be used to deliver therapeutic radiation directly to cancer cells.

[4][5]

Israeli hospitals, researchers and biotechnology companies continue advancing radiopharmaceuticals, cellular therapies and other precision approaches. Not every innovation is suitable or available for every patient - treatment decisions remain with the treating specialists.

For an international patient, the question is not only "What treatment exists?" but "Which advanced option is relevant to my specific disease - and how do I reach the right expertise?"

RKM INTL coordinates access to Israeli medical expertise for complex international cases.

[5][6]